Ibrahim Noha, Weissgold Sydni A, Brink Lucy, Mahgoub Ibtihal, Carter Ben, Sethna Vaheshta, Odendaal Hein
Department of Forensic and Neurodevelopmental Sciences, Institute of Psychiatry, Psychology and Neuroscience, Kings College London, London, UK.
Social Genetic Developmental Psychiatry Centre, Institute of Psychiatry, Psychology and Neuroscience, Kings College London, London, UK.
J Child Psychol Psychiatry. 2025 Oct;66(10):1606-1620. doi: 10.1111/jcpp.14152. Epub 2025 Mar 26.
Placental malperfusion, categorised into maternal vascular malperfusion (MVM) and foetal vascular malperfusion (FVM), is a main placental pathology known to affect placental functioning and offspring outcomes. The aim of this review is to evaluate the association between exposure to placental malperfusion and offspring neurodevelopment from birth to 18 years of age.
Following the registered protocol on Prospero, Medline, Cochrane, CINHAL, Embase and PsycINFO databases were searched systematically from inception to 01/11/2023. Included were publications examining exposure to placental malperfusion detected on histopathological examination and clinically measured neurodevelopmental outcomes. Publications on multi-pregnancies or animals, exposure to malformations, surgical or medical interventions, review and opinion articles, or those not translated to English, were excluded. Grey literature search and forward and backward citation chaining were performed. The Joanna Briggs Institute's checklists were used for quality assessment. Three studies were pooled using percentages of adjusted associations.
Nine observational studies fulfilled the eligibility criteria. The included neurodevelopmental outcomes were assessed from 5 days to 8 years when age of assessment is reported. Four publications showed an association between exposure to MVM and poor neurodevelopment at 10-40 months and 8 years, however, no association was observed when examining preterm infants up to 24 months. Conversely, in the six studies examining exposure to FVM, FVM association with neurodevelopmental disorders was reported in two studies looking at preterm infants assessed at 24 months and 8 years and better neurodevelopmental scores in other two studies at 10-40 months.
The pattern of association between MVM and FVM with neurodevelopmental outcomes varied among the included studies. Clinical and methodological heterogeneities and poor reporting of relevant populations' characteristics hindered full understanding of the results. Methodologically rigorous research is required to help utilise histopathological findings of placental malperfusion in predicting offspring's neurodevelopmental outcomes.
胎盘灌注不良分为母体血管灌注不良(MVM)和胎儿血管灌注不良(FVM),是一种已知会影响胎盘功能和子代结局的主要胎盘病理状态。本综述的目的是评估胎盘灌注不良暴露与子代从出生到18岁神经发育之间的关联。
按照在国际前瞻性系统评价注册平台(Prospero)上注册的方案,对Medline、Cochrane、护理学与健康领域数据库(CINHAL)、Embase和PsycINFO数据库从建库至2023年11月1日进行系统检索。纳入的文献为检查组织病理学检查中检测到的胎盘灌注不良暴露情况以及临床测量的神经发育结局的出版物。排除关于多胎妊娠或动物、暴露于畸形、手术或医学干预、综述和观点文章,或未翻译成英文的文献。进行了灰色文献检索以及向前和向后的引文链追踪。使用乔安娜·布里格斯循证卫生保健中心(Joanna Briggs Institute)的核对清单进行质量评估。使用调整后关联的百分比对三项研究进行汇总。
九项观察性研究符合纳入标准。当报告评估年龄时,纳入的神经发育结局评估时间为5天至8岁。四项出版物显示,暴露于MVM与10 - 40个月和8岁时的神经发育不良之间存在关联,然而,在检查24个月以下的早产儿时未观察到关联。相反,在六项检查暴露于FVM的研究中,两项研究报告了FVM与24个月和8岁时评估的早产儿神经发育障碍之间的关联,另外两项研究报告在10 - 40个月时神经发育得分更好。
在所纳入的研究中,MVM和FVM与神经发育结局之间的关联模式各不相同。临床和方法学的异质性以及相关人群特征报告不足阻碍了对结果的全面理解。需要进行方法学严谨的研究,以帮助利用胎盘灌注不良的组织病理学发现来预测子代的神经发育结局。